Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

BACKGROUND: A growing body of evidence suggests that the plasma concentration of the neurofilament light chain (NfL) might be considered a plasma biomarker for the screening of neurodegeneration in Alzheimer’s disease (AD). METHODS: With a single molecule array method (Simoa, Quanterix), plasma NfL...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewczuk, Piotr, Ermann, Natalia, Andreasson, Ulf, Schultheis, Christian, Podhorna, Jana, Spitzer, Philipp, Maler, Juan Manuel, Kornhuber, Johannes, Blennow, Kaj, Zetterberg, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064615/
https://www.ncbi.nlm.nih.gov/pubmed/30055655
http://dx.doi.org/10.1186/s13195-018-0404-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064615/
https://www.ncbi.nlm.nih.gov/pubmed/30055655
http://dx.doi.org/10.1186/s13195-018-0404-9

Ejemplares similares